Loading...
01/11 03:09
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary indicates a decline in revenue, gross margin, and increased net loss, suggesting financial struggles. The Q&A section highlights a new product with potential, but lacks concrete sales projections. The absence of a share repurchase program and increased operational costs further contribute to a negative outlook. Despite potential in new product offerings, the overall financial health appears weak, leading to a likely negative stock price movement.
Total Revenue RMB 97.1 million (down from RMB 149.2 million, a decrease of 34.9% year-over-year) due to ongoing refinements to product range and optimization of supplier and merchant network.
Revenue from Sales of Merchandise RMB 75.5 million (specific year-over-year change not provided) impacted by product range refinements.
Revenue from Marketplace Business RMB 19.4 million (specific year-over-year change not provided) affected by ongoing product range optimization.
Gross Margin 48.3% (down from 49.4% year-over-year) due to customer loyalty towards private labels and effective product creation strategy.
Fulfillment Expense RMB 16.4 million (down from RMB 28.8 million, a decrease of 43% year-over-year) due to reduced staff costs and lower warehousing and logistics expenses.
Sales and Marketing Expense RMB 30.2 million (down from RMB 38.5 million, a decrease of 21.5% year-over-year) primarily due to an increase in business promotion expenses.
Technology and Content Expense RMB 8.5 million (down from RMB 12 million, a decrease of 29.2% year-over-year) largely due to reduced personnel costs.
General and Administrative Expense RMB 71.1 million (up from RMB 44.5 million, an increase of 59.8% year-over-year) mainly due to severance payments from staff restructuring and impairment charges.
Total Operating Expense RMB 126.2 million (up from RMB 109.8 million, an increase of 14.5% year-over-year) reflecting the overall increase in operational costs.
Loss from Operation RMB 77.7 million (up from RMB 39.5 million, an increase of 96.2% year-over-year) due to increased operating expenses.
Net Loss RMB 85 million (up from RMB 65.9 million, an increase of 29% year-over-year) reflecting higher operational losses.
Adjusted Net Loss RMB 84.5 million (up from RMB 65 million, an increase of 30% year-over-year) indicating continued financial challenges.
Basic and Diluted Net Loss per Share RMB 0.04 (up from RMB 0.03 year-over-year) reflecting increased losses per share.
Cash and Cash Equivalents RMB 242.8 million as of December 31, 2024 (specific year-over-year change not provided) indicating liquidity position.
Probiotic Sales: Achieved sales of nearly RMB 5 million in Q4 2024 and over RMB 6 million in Q1 2025.
New Life Coffee Launch: Launched at the end of March 2025, generating sales of over RMB 5 million in just 1.5 months.
SUYE Pro Firming Series: Generated over RMB 20 million in total sales in 2024.
SUYE Pro Solution Launch: Planned for 2025 to enhance the SUYE Pro series.
Tea Therapy Program: Launched in March 2025, achieving 91% retention rate among first 150 participants.
Recruitment for Tea Therapy Program: Plans to recruit 1,000 tea enthusiasts by April 2025.
Gross Margin Improvement: Overall gross margin improved to 49.4%.
User Repurchase Rate: Maintained a strong user repurchase rate of 71.9%.
Operational Realignment: Enhanced organizational structure and improved operational efficiency.
Organic Health Strategy: Positioned as key strategic objective for future development.
Shift to Experience Ecosystem: Transitioning from a traditional transaction platform to a dynamic experience ecosystem.
Competitive Pressures: Yunji faces ongoing competitive pressures in the organic health market, which may impact sales and market share.
Regulatory Issues: The company acknowledges potential regulatory challenges that could affect its operations and product offerings.
Supply Chain Challenges: There are risks associated with supply chain optimization, which may lead to short-term impacts on sales.
Economic Factors: The company is adapting to evolving market dynamics, indicating potential economic risks that could affect revenue.
Operational Costs: Increased near-term expenses, including severance payments and impairment charges, may affect profitability.
Market Dynamics: Changes in market dynamics and consumer preferences could pose risks to revenue generation.
Strategic Objective: Positioning organic health as the key strategic objective for future development.
Operational Realignment: Enhanced organizational structure, improved operational efficiency, and optimized business layout.
Private Label Growth: Strengthening private label brand SUYE with a strategic upgrade in messaging and visual identity.
New Business Initiatives: Launching the therapy program in 2025, combining wellness experiences with product offerings.
Product Innovation: Focus on high-margin, high-repurchase rate products to enhance profitability.
Community Building: Creating health-focused communities through innovative wellness programs.
Revenue Expectations: Total revenue for Q1 2024 was RMB 97.1 million, down from RMB 149.2 million year-over-year.
Gross Margin: Gross margin improved to 49.4% in 2024.
Operating Expenses: Total operating expenses increased to RMB 126.2 million in Q1 2024.
Net Loss: Net loss was RMB 85 million in Q1 2024, compared to RMB 65.9 million a year ago.
Cash Position: As of December 31, 2024, total cash and cash equivalents were RMB 242.8 million.
Future Investments: Focus on strategic investments in categories with potential for sustainable growth.
Share Repurchase Program: None
The earnings call reveals significant revenue decline, increased operating losses, and cash concerns, indicating poor financial health. Despite efforts in product development and market strategy, the declining consumer confidence and ineffective cost management have led to a deteriorating financial position. The lack of positive guidance and absence of a shareholder return plan further contribute to a negative outlook. With no market cap information, assuming a small-cap impact, the stock is likely to experience a strong negative reaction.
The earnings call summary indicates a decline in revenue, gross margin, and increased net loss, suggesting financial struggles. The Q&A section highlights a new product with potential, but lacks concrete sales projections. The absence of a share repurchase program and increased operational costs further contribute to a negative outlook. Despite potential in new product offerings, the overall financial health appears weak, leading to a likely negative stock price movement.
The earnings call reveals declining revenues, increased losses, and rising expenses, indicating financial struggles. Despite a focus on high-margin products and breakeven goals, the lack of a share repurchase program or dividend hikes, coupled with competitive and regulatory pressures, further dampens sentiment. The Q&A highlights new product launches but lacks concrete sales projections, adding uncertainty. The negative financial performance outweighs optimistic product developments, suggesting a likely negative stock price movement in the short term.
Yunji's earnings call presents mixed signals: a significant revenue decline and ongoing losses despite cost-cutting measures and strong gross margins. The lack of shareholder return initiatives and unclear management responses in the Q&A section add to the uncertainty. While there is optimism in offline expansion and product development, the absence of a clear strategy to integrate online and offline services and the economic challenges faced suggest a negative sentiment. The market is likely to react negatively over the next two weeks, especially given the revenue drop and lack of guidance.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
